Search Results 631-640 of 18279 for Immunode

1. A Study to Assess the Effectiveness, Safety, and Tolerability of Brensocatib in Participants with Non-Cystic Fibrosis Bronchiectasis (ASPEN) - Mayo Clinic

   Current smokers as defined per Centers for Disease Control (CDC). 4. Known or suspected immunodeficiency disorder, including history of invasive

2. A Study of Idasanutlin in Combination With Obinutuzumab in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and in Combination With Rituximab in R/R Diffuse Large B-Cell Lymphoma (DLBCL) Participants - Mayo Clinic

   Positive for human immunodeficiency virus (HIV) or hepatitis B or C; Receipt of a live virus vaccine within 28 days prior to Day 1 of Cycle 1; Poor ...

3. Efficacy and Safety of Maribavir in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment - Mayo Clinic

   Have positive results for human immunodeficiency virus (HIV). Subjects must have a confirmed negative result within 3 months of study entry or be willing to ...

4. Study Of 225Ac-ABD147 To Establish Optimal Dose In Patients With SCLC And LCNEC Of The Lung That Previously Received Platinum-based Chemotherapy - Mayo Clinic

   * Has human immunodeficiency virus infection; patients who are taking an effective antiviral therapy with undetectable viral load prior to C1D1 are eligible.

5. A Study to Test the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer - Mayo Clinic

   Patients with a history of human immunodeficiency virus (HIV) infection must be on an effective anti-retroviral regimen utilizing agents that do not ...

6. A Study of the Safety and Effectiveness of Benralizumab to Treat Patients With Severe Uncontrolled Asthma - Mayo Clinic

   A history of known immunodeficiency disorder. Current smokers or former smokers with a smoking history of ≥10 pack years. Previously received benralizumab ...

7. Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer - Mayo Clinic

   Immunocompromised patients and patients known to be human immunodeficiency virus (HIV) positive and currently receiving antiretroviral therapy; Note ...

8. Immune Response to Pneumococcal Polysaccharide Vaccine (23-valent) Predicts Asthma Status and Outcomes in Late Adolescents With Asthma - Mayo Clinic

   Diagnosis of an immunodeficiency (primary and secondary); Previous or current diagnosis of a Rheumatological disorders (Rheumatoid arthritis, Lupus, Sjögren ...

9. Phase I Study Of BL0020, A Novel Anti-tumor Drug, In Adult Subjects With Advanced Solid Tumors - Mayo Clinic

   Patients who have a known diagnosis of Human Immunodeficiency Virus (HIV) infection or HIV antibody test positive in screening. 11. Patients with active ...

10. Dayne H. Voelker, M.D. - Doctors and Medical Staff - Mayo Clinic

    Clinical Immunology Society School of Primary Immunodeficiency 2021 Attendee Washington University Barnes-Jewish Hospital. 2018. Chrysalis Project Award ...